Hi,
moomoo ID:NaN
Log Out
English
Back
Download
Log in to access Online Inquiry
Quotes
Detailed Quotes
Company Overview
Company ProfileCompany Executives
Financial Analysis
Main CompositionKey IndicatorsFinancial Statement
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > RAIN Rain Oncology > Detailed Quotes

RAIN Rain Oncology

Watchlist
9.750
+0.020+0.21%
Close  02/03 16:00 ET
9.7500.0000.00%
Post Mkt Price 02/03 16:02 ET
High
10.106
Open
9.590
Turnover
1.51M
Low
9.480
Pre Close
9.730
Volume
153.18K
Market Cap
342.63M
P/E(TTM)
Loss
52wk High
14.480
Shares
35.14M
P/E(Static)
Loss
52wk Low
2.150
Float Cap
88.02M
Bid/Ask %
33.33%
Historical High
23.900
Shs Float
9.03M
Volume Ratio
0.64
Historical Low
2.150
Dividend TTM
--
Div Yield TTM
--
P/B
4.21
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.70%
Amplitude
6.44%
Avg Price
9.849
Lot Size
1
Float Cap
88.02M
Bid/Ask %
33.33%
Historical High
23.900
Shs Float
9.03M
Volume Ratio
0.64
Historical Low
2.150
Dividend TTM
--
P/B
4.21
Dividend LFY
--
Turnover Ratio
1.70%
Amplitude
6.44%
Avg Price
9.849
Lot Size
1
Post-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast

News

Comment

News

Announcement

Company Overview More
Rain Oncology, Inc. is a clinical-stage precision oncology company, which focuses on developing and implement the precision oncology therapies for patients suffering from cancer. The company was founded by Avanish Vellanki and Robert Doebele in April 2017 and is headquartered in Newark, CA.
CEO： Mr. Avanish Vellanki
Market： NASDAQ
Listing Date： 04/23/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Get Started
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist